Eli Lilly
Canvas Category OEM : Pharmaceutical
Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: “Take what you find here and make it better and better.” More than 145 years later, we remain committed to his vision through every aspect of our business and the people we serve starting with those who take our medicines, and extending to health care professionals, employees and the communities in which we live.
Assembly Line
IONETIX closes financing led by Tees River and Eli Lilly and Company
IONETIX Corporation, a leading cyclotron technology innovator and isotope manufacturer for diagnostic and therapeutic applications, announced a financing which included Eli Lilly and Company, as well as existing shareholders of the Company led by Tees River Limited.
The financing follows prior Actinium supply and convertible debt agreements with POINT Biopharma, which has since been acquired by Lilly. The financing underscores the robust strategic interest in Ionetix’s differentiated technology and the Company’s continued leadership in isotope manufacturing.
With this financing, the company meaningfully extends its cash runway to fund continued development of its core technology offerings and expansion of the current cyclotron network in support of its strategic growth plans in the late-stage clinical and commercial settings. Capitalizing on the growth derived from new therapeutics programs, Ionetix aims to fill the market need resulting from the capacity-constrained isotope manufacturing landscape.
Zephyr AI Raises $111 Million in Series A Financing
Zephyr AI, Inc., a healthcare technology company committed to developing fast and explainable Artificial Intelligence (AI) solutions to democratize precision medicine, announced it has successfully closed a $111 million Series A funding round with participation from Revolution Growth, Eli Lilly & Company, Jeff Skoll, and EPIQ Capital Group, among others. The company is developing improved data federation tools along with various machine learning algorithms in the areas of oncology and cardiometabolic disease.
The new funds will enable Zephyr AI to further enhance its analytical speed and fortify its extensive collection of training and validation data sets. Moreover, the funds will support the expansion of the company’s scientific and commercial teams to expedite the delivery of its rapidly growing pipeline of insights to the market.
Why Convergence of IT/OT Needs to Include ET
The increased sophistication of intelligent devices and associated software drive the need for tighter integration of the IT and OT domains to gain new insight from known information. However, in the digital data environment of IIoT, engineering technology, those technologies that create virtual models must be included in the convergence conversation. While inclusion of ET may have been implied in the past, its use in the current and future work environment cannot be underestimated as modeling tools become essential to managerial or technical decision making.
He shared a real-world example of IT/OT/ET converging at Lilly. An HMI graphics card needed replacement due to a defective component. The replacement card required a driver that was incompatible with the existing version of Windows in that operation. A Windows upgrade would affect other applications. In this case, the obsolescence of a single component on a graphics card cascaded into a project to upgrade the HMI and all other affected applications and interfaces. This seemingly simple issue required extensive IT/OT/ET collaboration to solve.
In his presentation, Mr. Ruth shared an IT/OT/ET convergence story that has spawned a whole new service business Convergence of IT/OT Needs ETfor Danfoss, the Smart Store. Per Ruth, it’s all about Big Data and a new way of doing business enabled by IIoT technology to increase operational effectiveness and control, and reduce costs. This supplier of refrigeration equipment, compressors, and controllers for supermarkets required an integrated solution to help customers view operational data at a more granular level.
🧪 XtalPi Announces Collaboration with Lilly, Using AI + Robotics to Uncover First-in-class Therapeutics
XtalPi Inc., a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, announced an AI drug discovery collaboration of up to $250 million in upfront and milestone payments with Eli Lilly and Company. The collaboration will leverage XtalPi’s integrated AI capabilities and robotics platform to de novo design and deliver drug candidates for an undisclosed target.